stockrow
Friday 6 November 2026
Export PHR’s income statement to Excel — free account
Phreesia, Inc.
PHR Healthcare Health Information Services
Phreesia, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $480.6 million, up 14.5% from fiscal 2025.
- Revenue
- +10.4%
- EPS
- +200.0%
- Free cash flow
- +43.5%
- Total debt
- +3,191.9%
Quarter to July 2026, against a year earlier
12.56
0.15
−1.18%
Follow PHR
Alert me
| Jan '26 | Jan '25 | Jan '24 | Jan '23 | Jan '22 | Jan '21 | Jan '20 | Jan '19 | Jan '18 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 6 | 4 | 3 | 3 | 6 | — | — | — |
P/E ratio |
440.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
0.65 | 5.93 | 4.23 | 11.83 | 11.30 | 24.09 | 5.32 | — | — |
P/S ratio |
1.64 | 3.90 | 3.90 | 7.00 | 7.30 | 17.74 | 5.04 | 0.00 | 0.00 |
P/FCF ratio |
14.50 | 197.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(1.95) | (3.98) | (5.28) | (1.62) | 5.47 | 5.09 | (0.63) | (12.16) | — |
P/Operating CF |
23.44 | 100.83 | (451.66) | (123.65) | (40.97) | 646.94 | 493.98 | 24.85 | 24.85 |
Beneish M-Score |
(2.15) | (3.42) | (3.37) | (3.26) | (2.23) | (2.45) | (2.86) | — | — |
P/B ratio |
2.34 | 6.19 | 5.53 | 6.83 | 3.73 | 10.02 | 6.18 | 0.00 | 0.00 |
Price to Tangible BV |
9.03 | 10.19 | 9.66 | 8.10 | 4.20 | 10.46 | 6.27 | 0.00 | 0.00 |
EV/Sales |
1.85 | 3.74 | 3.69 | 6.40 | 5.89 | 16.35 | 4.51 | 0.00 | 0.00 |
EV/EBITDA |
31.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 537.10 | 0.00 | 0.00 |
EV/Operating CF |
11.30 | 48.49 | (40.63) | (19.95) | (16.82) | 841.25 | 681.45 | (818.39) | (818.39) |
EV/FCF |
16.37 | 189.37 | (22.89) | (15.46) | (11.91) | (155.00) | (48.97) | (6.27) | (6.27) |
Quick Ratio |
1.25 | 1.38 | 1.38 | 2.89 | 5.17 | 4.51 | 3.18 | 0.63 | 0.91 |
Current Ratio |
1.53 | 1.78 | 1.78 | 3.32 | 5.65 | 4.95 | 3.72 | 1.19 | 1.37 |
Net Debt/EBITDA |
3.58 | 2.70 | 0.78 | 1.12 | 3.22 | 28.08 | (63.41) | 6.36 | (55.79) |
Debt/Assets |
26.44% | 2.10% | 1.46% | 2.39% | 2.94% | 3.80% | 15.03% | 51.32% | 0.00% |
Debt/Equity |
0.52 | 0.03 | 0.02 | 0.03 | 0.03 | 0.05 | 0.23 | (6.78) | 0.00 |
Asset Turnover |
0.91 | 1.11 | 0.96 | 0.65 | 0.52 | 0.61 | 1.14 | 3.37 | 1.37 |
Operating CF/Net income |
34.18 | (0.55) | 0.24 | 0.51 | 0.63 | (0.11) | (0.01) | 0.05 | 0.29 |
Capex/Depreciation |
(0.70) | (0.80) | (0.81) | (0.96) | (1.29) | (1.01) | (0.75) | (0.70) | (1.00) |
Interest Coverage |
(0.95) | (24.75) | (73.61) | (71.33) | (1,478.70) | (210.42) | — | — | — |
| 0.77% | (22.67%) | (50.77%) | (49.96%) | (34.72%) | (14.95%) | 167.58% | 23.91% | 20.16% | |
| 0.44% | (15.43%) | (36.98%) | (40.75%) | (28.78%) | (11.24%) | (83.87%) | (152.75%) | (65.59%) | |
ROIC |
(0.94%) | (19.24%) | (50.37%) | (91.98%) | (61.88%) | (28.17%) | (27.00%) | (24.33%) | (6.22%) |
Return on Tangible Assets |
1.97% | (51.83%) | (133.59%) | (85.89%) | (33.51%) | (11.19%) | (82.61%) | (230.94%) | (169.65%) |
Average Days of Receivables |
117.44 | 64.01 | 66.45 | 66.78 | 68.92 | 71.32 | 64.29 | 58.73 | 56.28 |
Research and Development Expense of Revenue |
25.28% | 27.96% | 31.53% | 32.48% | 24.51% | 15.22% | 14.92% | 14.36% | 14.25% |
Selling, General and Administrative Expense of Revenue |
37.48% | 47.10% | 63.69% | 82.46% | 82.11% | 56.12% | 50.34% | 46.49% | 54.61% |
Intangible Assets out of Total Assets |
0.38 | 0.27 | 0.29 | 0.12 | 0.09 | 0.03 | 0.01 | 0.03 | 0.00 |
Share Based Compensation of Revenue |
14.04% | 15.95% | 20.10% | 20.92% | 16.95% | 9.07% | 4.95% | 1.45% | 1.01% |
Graham Net Nets |
(0.06) | 0.05 | 0.06 | 0.09 | 0.20 | 0.08 | 0.12 | 0.65 | 0.65 |
Graham Number |
1.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
0.23% | (3.58%) | (9.89%) | (8.96%) | (7.47%) | (1.02%) | (44.88%) | (9.01%) | (9.01%) |
Free Cash Flow Yield |
6.90% | 0.51% | (4.13%) | (5.92%) | (6.78%) | (0.59%) | (1.83%) | (25.05%) | (25.05%) |
Revenue per Share |
8.05 | 7.29 | 6.53 | 5.36 | 4.27 | 3.76 | 6.15 | 54.14 | 51.87 |
Operating CF per Share |
1.32 | 0.56 | (0.59) | (1.72) | (1.50) | 0.07 | 0.04 | (1.15) | (7.24) |
Capex per Share |
(0.41) | (0.42) | (0.46) | (0.50) | (0.62) | (0.47) | (0.61) | (5.33) | (7.77) |
Free Cash Flow per Share |
0.91 | 0.14 | (1.05) | (2.22) | (2.11) | (0.40) | (0.57) | (6.48) | (15.01) |
Cash per Share |
1.24 | 1.46 | 1.60 | 3.37 | 6.29 | 5.54 | 4.45 | 0.84 | 6.82 |
Shareholders Equity per Share |
5.64 | 4.60 | 4.61 | 5.49 | 8.36 | 6.66 | 5.02 | (2.43) | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
5.64 | 4.60 | 4.61 | 5.49 | 8.36 | 6.66 | 5.02 | (2.43) | 0.00 |
Free Cash Flow |
54.42 | 8.29 | (57.47) | (116.33) | (105.51) | (15.68) | (11.49) | (11.96) | (23.11) |
Working Capital |
96.60 | 89.26 | 85.57 | 183.40 | 317.92 | 217.28 | 96.19 | 5.39 | 9.33 |
Capital Expenditures |
(24.40) | (24.09) | (25.10) | (26.20) | (30.80) | (18.57) | (12.32) | (9.83) | (11.96) |
Net Current Asset Value |
(46.74) | 79.68 | 76.81 | 180.20 | 309.15 | 208.91 | 74.65 | (30.43) | 34.31 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.05 | 0.06 | 0.07 | 0.09 | 0.14 | 0.12 | 0.10 | 0.10 | 0.15 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
1.72 | 1.27 | 1.83 | 1.26 | 0.69 | 0.69 | 1.13 | 0.99 | 0.91 |
Cash ROIC |
9.28% | 2.32% | (16.69%) | (24.58%) | (14.15%) | (3.17%) | (5.32%) | (43.54%) | (13.82%) |
Accounts Receivable Turnover |
4.21 | 6.06 | 6.13 | 6.13 | 6.15 | 5.83 | 6.56 | 7.04 | 5.62 |
Accounts Payable Turnover |
18.03 | 19.14 | 12.84 | 13.70 | 17.12 | 10.07 | 9.16 | 12.43 | 9.36 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
27.18 | 15.21 | 24.96 | 36.20 | 22.96 | 30.58 | 49.11 | 37.00 | 27.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
114.12 | 69.24 | 58.13 | 45.83 | 34.66 | 25.52 | 19.03 | 14.19 | 14.21 |
Average Payables |
8.55 | 7.05 | 9.66 | 7.98 | 4.75 | 5.20 | 4.88 | 2.98 | 3.18 |
Average Assets |
526.10 | 379.37 | 370.19 | 432.27 | 410.57 | 242.71 | 109.01 | 29.63 | 58.20 |
Average Common Equity |
301.01 | 258.13 | 269.63 | 352.55 | 340.29 | 182.59 | (54.55) | (189.33) | (189.33) |
Columns are period end dates · fundamentals updated 26 Oct 2026